John Connolly | BiotechTV

top of page

Nov 4, 2023

Parker Institute for Cancer Immunotherapy's John Connolly on what he is seeing at #SITC23

John Connolly describes trends he is seeing in cell therapy, bi-specific engagers, myeloid checkpoint targets, and combinations.

The latest on immunotherapy with John Connolly.

Jan 11, 2023

Bright Minds

The latest on immunotherapy with John Connolly.

Parker Institute's John Connolly provides an update on the latest in cancer immunotherapy at #JPM23.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE